肠溶片

  • 网络enteric-coated tablets;enteric tablet;EC-MPS
肠溶片肠溶片
  1. 目的:评价复方阿嗪米特肠溶片治疗儿童假日功能性消化不良的临床疗效和安全性。

    Objective : To evaluate the efficacy and safety of complex azintamide enteric tablet in the treatment of children with functional dyspepsia during holiday .

  2. 奥沙普秦肠溶片HPLC测定法及其人体生物等效性研究

    The bioequivalence of oxaprozin enteric tablet in healthy volunteers measured with HPLC

  3. HPLC测定替硝唑结肠定位肠溶片含量和有关物质检查

    HPLC Determination of Related Substances and Content of Tinidazole Colon Targeting Tablets

  4. HPLC法测定比沙可啶肠溶片的有关物质

    Determination of Related Substances in Bisacodyl Enteric-coated Tablets by HPLC

  5. HPLC法测定阿司匹林肠溶片中游离水杨酸含量

    Determination of Free Salicylic Acid in Aspirin Enteric - coated Tablets by HPLC

  6. HPLC法测定泮托拉唑钠肠溶片的含量

    Determination of Pantoprazole Sodium Enteric-Coated Tablets by HPLC

  7. HPLC测定阿司匹林肠溶片的含量

    Content determination of Aspirin Enteric-Coated Tablets by HPLC

  8. 奥沙普秦肠溶片治疗类风湿关节炎的III期临床试验

    Phase III trials of oxaprozin enteric coated tablet in treatment of rheumatoid arthritis

  9. 雷贝拉唑钠肠溶片早期联合抗生素治疗Hp阳性胃溃疡患者97例疗效观察

    Effect observation of therapeutic alliance of 97 cases Hp positive gastric ulcer by sodium rabeprazole enteric-coated tablets

  10. RP-HPLC法测定人血浆中兰索拉唑肠溶片血药浓度

    RP-HPLC determination of lansoprazole enterosoluble tablets in human plasma

  11. 目的建立一种HPLC检测法,以测定人体血浆中奥沙普秦的药物浓度,并对两种奥沙普秦肠溶片生物等效性进行评价。

    Aim An HPLC method was established for the study on pharmacokinetics and bioequivalence of oxaprozin enteric tablet in healthy volunteers .

  12. 低分子肝素合用阿司匹林肠溶片治疗脑梗死患者DVT的临床观察

    Clinical observation of low-molecular-weight heparin and aspirin enteric-coated tablets therapy on deep vein thrombosis

  13. 目的:研究po氨糖美辛肠溶片在20名健康志愿者体内的相对生物利用度和生物等效性。

    OBJECTIVE : To study the relative bioavailability and bioequivalence of glucosamine indometacin enteric-coated tablets in 20 healthy volunteers .

  14. 两项药效学试验结果表明:缓释片具有显著抑制角叉菜胶引起大鼠足爪肿(P<0.001),且与肠溶片比较,消炎作用持久。

    The results showed that buffer tablets could inhibit the swelling of toe of rats caused by carrageenin significantly ( p < 0.001 ), and its diminishing inflammation was longer than that of enteric coated tablets .

  15. 方法:采用UV法测定盐酸二甲双胍肠溶片在酸及缓冲液中的释放度及含量。

    METHOD : The rate of release and content of metformin hydrochloride enteric coated tablets were determinated by UV . RESULTS : The excipient is not interference .

  16. 结果:马齿苋水煎剂灌胃联合灌肠对小鼠结肠组织中IL-10的提高和IL-8的降低均能取得与西药柳氮磺胺吡啶肠溶片相当的作用。

    Results : The decoction of fed purslane United enema colon tissues of mice increased IL-10 and IL-8 can reduce the acquisition and Western Sulfasalazine enteric-coated tablets considerable role .

  17. 试验组20例病人服5氨基水杨酸肠溶片,0.8g,tid;

    Twenty patients of trial group received 5-amino salicylic acid enteric-coated tablet 0.8 g , tid for 6 wk .

  18. 目的:观察怡开(胰激肽原酶肠溶片)对2型糖尿病(T2DM)早期肾病的疗效。

    Objective : To study the curative effect of YiKai ( pancreatic kininogenase tablets ) in the treatment of early diabetic nephropathy of type 2 diabetes .

  19. 5ASA肠溶片组和SASP组的不良反应分别为11.48%和23.33%。

    The rate of drug adverse events in 5 ASA group and SASP group was 11.48 % and 23.33 % respectively .

  20. 目的评价国产5氨基水杨酸(5ASA)肠溶片治疗溃疡性结肠炎(UC)的疗效和安全性及该药的口服吸收情况。

    Objective To assesses the efficacy , safety and oral absorption of a locally manufactured 5 aminosalicylic acid ( 5 ASA ) enteric coated tablet on patients with ulcerative colitis ( UC ) .

  21. 该胶囊剂耐酸性好,人工肠液中释药快,在8名健康志愿者体内的AUC为市售红霉素肠溶片的1.99倍,且个体差异小。

    The dissolution of the micro-granules was rapid in artificial intestinal liquid . In 8 volunteers , the AUC of prepared capsules was 1.99 times as much as that of conventional enteric coated tablets .

  22. 目的建立一种非水毛细管电泳法(NACE)分离非甾体抗炎药物,并对奥沙普秦肠溶片进行定量分析。

    OBJECTIVE To establish a method of nonaqueous capillary electrophoresis ( NACE ) to separate non-steroidal anti-inflammatory drugs ( NSAIDs ) and determine the content of oxaprozin in enteric-coated tablet .

  23. 方法:对8例健康男性受试者接受单次口服2000mg替硝唑结肠定位肠溶片后的药动学进行了研究。采用HPLC法测定血浆中药物浓度。

    Methods : After a single oral dose of tinidazole colon-specific enteric-coated tablets ( 2000mg ) was given to 8 healthy male volunteers in the open randomized study , their plasma drug level were measured by HPLC technique .

  24. 目的制备性质稳定的兰索拉唑肠溶片。

    OBJECTIVE To design a more stable formulation of Lansoprazole enteric-tablets .

  25. 小剂量阿司匹林肠溶片致全血细胞减少

    Low - dose aspirin enteric - coated tablet resulting in panhematopenia

  26. 前言:目的:提高奥沙普秦肠溶片的释放度。

    Objective : To improved the dissolution of Oxiprozin Enteric-coated Tablets .

  27. 雷贝拉唑钠肠溶片体外释放度比较研究

    Comparative Study on the Release Rate of Rabeprazole Sodium Enteric-coated Tablets

  28. 舍雷肽酶肠溶片对慢性鼻窦炎的疗效观察

    Clinical Effects of Serrapeptase Enteric-coated Tablets in Treatment of Chronic Sinusitis

  29. 小剂量乙酰水杨酸肠溶片中游离水杨酸检查标准的研究

    Study on Salicylic Acid in Aspirin Enteric-coated Tablets of Small Dosage

  30. 阿斯匹林肠溶片中游离水杨酸检查方法的改进

    An improved testing method of salicylic acid in aspirin enteric-coated tablets